Association of sarcoidosis and immune thrombocytopenia: Presentation and outcome in a series of 20 patients

Medicine

Volumn 90, Issue 4, 2011, Pages 269-278

  Mahévas, Matthieu ^a,b   Chiche, Laurent ^c   Uzunhan, Yurdagul ^b,d   Khellaf, Medhi ^a   Morin, Anne Sophie ^e   Le Guenno, Guillaume ^f   Péronne, Véronique ^g   Affo, Louis ^h   Lidove, Olivier ⁱ   Boutboul, David ^j   Dion, Genevieve ^b,d   Ducroix, Jean Pierre ^b,k   Papo, Thomas ⁱ   Pacheco, Yves ^b,l   Schleinitz, Nicolas ^c   Michel, Marc ^a   Godeau, Bertrand ^a,b   Valeyre, Dominique ^b,d  

^a HENRI MONDOR HOSPITAL   (France)

^b SPLF   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

^d UNIVERSITÉ PARIS 13   (France)

^e HÔPITAL JEAN VERDIER   (France)

^f University of Clermont Ferrand   (France)

^g Fran0ois Quesnay Hospital   (France)

^h HÔPITAL LOUIS MOURIER   (France)

ⁱ BICHAT HOSPITAL   (France)

^j SAINT LOUIS HOSPITAL   (France)

^k UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^l UNIVERSITÉ DE LYON   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MALE; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOIDOSIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MIDDLE AGED; PREDNISONE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SARCOIDOSIS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79959794417     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e31822618b3     Document Type: Article

References (28)

1. Agarwal V, Pal S, Agarwal A, Gupta RK, Mishra R. Thrombocytopenia as the presenting manifestation of sarcoidosis. J Assoc Physicians India. 2002;50:268-269.
2. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet. 2003;361:1111-1118. (Pubitemid 36369566)
3. Bourgain C, Sadoun D, Valeyre D, Wilhelm JF, Guillevin L, Battesti JP. ESarcoidosis associated with hemolytic anemia and autoimmune thrombocytopenia. Ann Med Interne (Paris). 1990;141:625-626.
4. Chakrabarti S, Behera D, Varma S, Bambery P. High-dose methyl prednisolone for autoimmune thrombocytopenia in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1997;14:188. (Pubitemid 27427353)
5. Dickerman JD, Holbrook PR, Zinkham WH. Etiology and therapy of thrombocytopenia associated with sarcoidosis. J Pediatr. 1972;81:758-764.
6. Field SK, Poon MC. Sarcoidosis presenting as chronic thrombocytopenia. West J Med. 1987;146:481-482. (Pubitemid 17061849)
7. Forde AM, Feighery C, Jackson J. Anti-monocyte cytoplasmic antibodies in granulomatous disease. Clin Immunol Immunopathol. 1996;81:88-95. (Pubitemid 26338253)
8. Fordice J, Katras T, Jackson RE, Cagle PT, Jackson D, Zaleski H, Asimacopoulos PJ. Massive splenomegaly in sarcoidosis. South Med J. 1992;85:775-778.
9. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996; 88:3-40. (Pubitemid 26230668)
10. Ina Y, Takada K, Yamamoto M, Sato T, Ito S, Sato S. Antiphospholipid antibodies. A prognostic factor in sarcoidosis? Chest. 1994;105: 1179-1183. (Pubitemid 24112811)
11. Israel HL, Patterson JR, Smukler NM. Latex fixation tests in sarcoidosis. Acta Med Scand Suppl. 1964;425:40-42.
12. Jersild M. The syndrome of Heerfordt (uveo-parotid fever), a manifestation of Boeck's sarcoid. Acta Med Scand. 1938; 97:322-328.
13. Khellaf M, Michel M, Schaeffer A, Bierling P, Godeau B. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. Haematologica. 2005;90:829-832. (Pubitemid 40897225)
14. Larner AJ, Dollery CT, Cox TM, Bloom SR, Scadding JG, Rees AJ. Life threatening thrombocytopenia in sarcoidosis. BMJ. 1990;300:317-319.
15. Madaule S, Lauque D, Sailler L, Arlet P, Carles P. ESplenomegaly in sarcoidosis: clinical features and outcome. Analysis of 17 cases. Rev Med Interne. 2004;25:348-356. (Pubitemid 38542844)
16. Mahevas M, Le Page L, Salle V, Lescure FX, Smail A, Cevallos R, Garidi R, Marolleau JP, Duhaut P, Ducroix JP. Thrombocytopenia in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2006;23:229-235. (Pubitemid 47596319)
17. Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S, Kambouchner M, Valeyre D, Chapelon-Abric C, Debre P, Piette JC, Gorochov G. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med. 2006;203:359-370. (Pubitemid 43290845)
18. Mullauer L, Emhofer J, Wohlfart S, Pichlhofer B, Stary S, Ebetsberger G, Mannhalter C, Chott A. Autoimmune lymphoproliferative syndrome (ALPS) caused by Fas (CD95) mutation mimicking sarcoidosis. Am J Surg Pathol. 2008;32:329-334. (Pubitemid 351172149)
19. Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS. Common variable immunodeficiency: a new look at an old disease. Lancet. 2008;372:489-502.
20. Prasse A, Katic C, Germann M, Buchwald A, Zissel G, Muller-Quernheim J. Phenotyping sarcoidosis from a pulmonary perspective. Am J Respir Crit Care Med. 2008;177:330-336. (Pubitemid 351198377)
21. Rajoriya N, Wotton CJ, Yeates DG, Travis SP, Goldacre MJ. Immune-mediated and chronic inflammatory disease in people with sarcoidosis: disease associations in a large UK database. Postgrad Med J. 2009;85:233-237.
22. Rebattu P, Coiffier B, Gindre D, Viala JJ, Perrin-Fayolle M. ESarcoidosis accompanied by severe acute peripheral thrombopenia. Probable immunologic nature. Nouv Presse Med. 1982;11:3274.
23. Rodeghiero F, Besalduch J, Michel M, Provan D, Grotzinger K, Thompson G. Treatment practices in adults with chronic immune thrombocytopeniaVa European perspective. Eur J Haematol. 2010;84:160-168.
24. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kuhne T, Ruggeri M, George JN. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386-2393.
25. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736-755.
26. Thomas LL, Alberts C, Pegels JG, Balk AG, von dem Borne AE. Sarcoidosis associated with autoimmune thrombocytopenia and selective IgA deficiency. Scand J Haematol. 1982;28:357-359. (Pubitemid 12071822)
27. Torralba KD, Quismorio FP Jr. Sarcoidosis and the rheumatologist. Curr Opin Rheumatol. 2009;21:62-70.
28. Weinberg I, Vasiliev L, Gotsman I. Anti-dsDNA antibodies in sarcoidosis. Semin Arthritis Rheum. 2000;29:328-331. (Pubitemid 30235984)